Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Soligenix (SNGX) Research & Development (2016 - 2025)

Soligenix (SNGX) has disclosed Research & Development for 16 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 63.51% year-over-year to $1.6 million, compared with a TTM value of $7.9 million through Sep 2025, up 135.2%, and an annual FY2024 reading of $5.2 million, up 57.68% over the prior year.
  • Research & Development was $1.6 million for Q3 2025 at Soligenix, down from $1.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.7 million in Q4 2024 and bottomed at $501158.0 in Q2 2024.
  • Average Research & Development over 5 years is $1.6 million, with a median of $1.7 million recorded in 2025.
  • The sharpest move saw Research & Development crashed 67.02% in 2023, then skyrocketed 241.94% in 2024.
  • Year by year, Research & Development stood at $2.5 million in 2021, then fell by 6.95% to $2.4 million in 2022, then plummeted by 67.02% to $777534.0 in 2023, then surged by 241.94% to $2.7 million in 2024, then crashed by 40.43% to $1.6 million in 2025.
  • Business Quant data shows Research & Development for SNGX at $1.6 million in Q3 2025, $1.7 million in Q2 2025, and $1.9 million in Q1 2025.